Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose
about
Replicon RNA Viral Vectors as VaccinesAn RNA nanoparticle vaccine against Zika virus elicits antibody and CD8+ T cell responses in a mouse modelPreclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses.Charge-altering releasable transporters (CARTs) for the delivery and release of mRNA in living animalsAdvances in the delivery of RNA therapeutics: from concept to clinical reality.Polymers in the Delivery of siRNA for the Treatment of Virus Infections.Nanomedicine advances in toxoplasmosis: diagnostic, treatment, and vaccine applications.Polymeric therapeutic delivery systems for the treatment of infectious diseases.Mechanism of action of mRNA-based vaccines.Plant viral and bacteriophage delivery of nucleic acid therapeutics.Bubbled RNA-Based Cargo for Boosting RNA Interference.Dendrimers as Nanocarriers for Nucleic Acid and Drug Delivery in Cancer Therapy.Efficient Targeting and Activation of Antigen-Presenting Cells In Vivo after Modified mRNA Vaccine Administration in Rhesus Macaques.Self-assembling protein nanoparticles: a promising tool against lethal influenza?The 'anti-hype' vaccine.Multiplexed RNAi therapy against brain tumor-initiating cells via lipopolymeric nanoparticle infusion delays glioblastoma progression.A new developing class of gene delivery: messenger RNA-based therapeutics.Modified mRNA-Based Vaccines Elicit Robust Immune Responses and Protect Guinea Pigs From Ebola Virus Disease.Engineering and physical sciences in oncology: challenges and opportunities.Moving towards improved vaccines for Toxoplasma gondii.mRNA vaccines - a new era in vaccinology.New Kids on the Block: RNA-Based Influenza Virus Vaccines.Endothelial siRNA delivery in nonhuman primates using ionizable low-molecular weight polymeric nanoparticles.Tools for translation: non-viral materials for therapeutic mRNA deliveryNanoparticle Vaccines Adopting Virus-like Features for Enhanced Immune PotentiationNew Vaccine Technologies to Combat Outbreak SituationsNanoparticle Vaccines Against Infectious DiseasesApplication of Dendrimers for the Treatment of Infectious DiseasesNucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
P2860
Q28076639-03C68B0B-C41E-4DDC-9EAC-E5AD46318852Q29365281-3C7AD72C-59D3-4346-84A8-4890DBE597A3Q30401521-524E3675-7A5B-4286-B91B-113AFED8FF3AQ37612455-D94CCBD1-CDEC-4619-9668-5911A6B6A738Q38706445-A597A91E-335E-46FD-BD66-786D4BC3DF80Q38889573-9A56E826-D747-4BF6-8F73-AED0576DFDE3Q39287046-3A8A62DF-57A0-41D2-946E-E1CF4908D4ABQ39386505-58BD3D1E-17E5-47AE-A5D1-0918AFADEC75Q39431058-4F4494DC-FE7F-4EF7-8314-694B70E2EA3EQ39441748-091FD52E-3913-4762-A510-665DBED49939Q41482524-519B124C-E3E2-4805-AFF7-64FCF504C783Q41734074-CEC0B404-56F2-41CC-8ABF-1E0D040BF3E1Q41993335-A8CE6A78-309C-4286-8565-291EC06B3CB8Q42019805-14F71E91-A432-490A-B317-82401146131DQ42696034-0152DAE9-85AD-421A-934A-FB6EBA47FAA0Q45869675-4D6DF7DD-91D8-44D4-9878-8D99EB264E49Q45873514-D03EC73C-A238-4E0E-9959-DA39D88C55C8Q47243721-4C016888-E8A2-448B-85F7-62A9D6CB174DQ47244877-320BF074-1495-4373-A476-C397DC020785Q47318857-53626033-0355-4F73-8847-857C566A3DE0Q47736893-13CC04ED-3141-47E6-A726-8BF42CD07E59Q52609655-EB775358-0FDF-4948-A477-15494195F235Q55513382-6E3D987A-7A7F-4393-B8EB-91D497F3A1F5Q56057560-479B71F7-5CBC-4BF0-AF8D-E17E0C4AE0CDQ56993652-992C5A9A-E8DA-4123-88CD-11087C04312EQ57072744-33F519A3-EC78-4189-8890-9C273DFCE492Q58583890-ACFD4234-A76A-4FBB-AB8A-8230BE602586Q58696083-E6369F24-F194-41A8-A07E-ACDA57767F3DQ58721961-B0B330A1-0FAF-41B9-8161-F0A2CF376949
P2860
Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dendrimer-RNA nanoparticles ge ...... challenges with a single dose
@en
Dendrimer-RNA nanoparticles ge ...... challenges with a single dose.
@nl
type
label
Dendrimer-RNA nanoparticles ge ...... challenges with a single dose
@en
Dendrimer-RNA nanoparticles ge ...... challenges with a single dose.
@nl
prefLabel
Dendrimer-RNA nanoparticles ge ...... challenges with a single dose
@en
Dendrimer-RNA nanoparticles ge ...... challenges with a single dose.
@nl
P2093
P2860
P50
P921
P356
P1476
Dendrimer-RNA nanoparticles ge ...... challenges with a single dose
@en
P2093
Christopher L Cooper
Daniel G Anderson
Hidde L Ploegh
Jasdave S Chahal
Jonathan K Tsosie
Justine S McPartlan
Lucas D Tilley
Omar F Khan
Saima M Sidik
P2860
P304
P356
10.1073/PNAS.1600299113
P407
P577
2016-07-05T00:00:00Z